Pharmalink elects three to board
July 4, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ann-Tove Kongsnes, Hilde Furberg, Olav Hellebø, Pharmalink, ab
Swedish speciality pharma firm Pharmalink AB has appointed Ann-Tove Kongsnes, Hilde Furberg and Olav Hellebø to its board of directors. …
Majority of consumed Viagra fake say researchers
July 3, 2014Manufacturing and Production, Sales and Marketing BMJ, ED, Pfizer, Sildenafil, counterfeit, erectile dysfunction, viagra
At least two-thirds of Pfizer’s erectile dysfunction drug Viagra used in the Netherlands may be illegal, researchers are warning. In …
Novartis faces data fraud charges in Japan
July 3, 2014Medical Communications, Sales and Marketing Diovan, Japan, Novartis, data, fraud, heart, valsartan
Novartis is facing criminal charges in Japan over the alleged falsifying of data for its once big-selling heart drug Diovan. …
Genentech to buy Seragon
July 3, 2014Sales and Marketing Genentech, Roche, breast cancer, oncology, serds
Roche subsidiary Genentech is to pay around $1.7 billion for biotech firm Seragon Pharmaceuticals to secure its portfolio of potential …
Prosensa makes two key appointments


July 3, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Prosensa, Willem W. van Weperen. Annalisa Jenkins
Dutch biopharma firm Prosensa has appointed Willem W. van Weperen as chief commercial officer and Dr Annalisa Jenkins to its …
World facing medical ‘dark ages’ over antibiotic resistance
July 2, 2014Medical Communications, Research and Development, Sales and Marketing Antibiotics, BRIC, Cameron, MINT, UK, o'neill, oneill, resistance
The UK Government has pledged to become a world leader in tackling antibiotic resistance in the face of a medical …
FDA breakthrough for Amgen
July 2, 2014Research and Development, Sales and Marketing Amgen, BiTE antibody blinatumomab, FDA, all, leukaemia
Amgen has taken a major step down the road to getting its investigational cancer drug blinatumomab onto the market after …
J&J completes $4 billion OCD sale
July 2, 2014Sales and Marketing J&J, JJ, Johnson and Johnson, Ortho-Clinical Diagnostics, carlyle, ocd
Johnson & Johnson has sold its Ortho-Clinical Diagnostics (OCD) business to private equity investor The Carlyle Group for ‘approximately $4 …
Fishawack buys Brighton comms agency
July 2, 2014Medical Communications Brighton, Facilitate, comms, fishawack
Medical communications firm Fishawack has acquired the UK, Brighton-based agency Facilitate as part of its
 ongoing purchasing strategy. Facilitate will …
PD-1 cancer race heats up as Merck takes lead
July 2, 2014Research and Development, Sales and Marketing ASCO, Cancer, Merck, melanoma, mk3475, oncology, pembrolizumab
Merck’s oncology drug pembrolizumab has taken a big step towards becoming Europe’s first PD-1 cancer treatment as the EMA accepts …
Reuters chief executive joins Pfizer board
July 2, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pfizer, james smith, reuters
Pfizer has appointed the chief executive of information and media giant Thomson Reuters to its board of directors. James Smith …
Doctors who miss cancer to be named and shamed
July 1, 2014Sales and Marketing Cancer, GPs, Hunt, NHS, UK, doctors, oncology
In a new government initiative doctors who consistently fail to diagnose signs of cancer could be publically named on an …
BASF and chemical giants building new MDI plant
July 1, 2014Manufacturing and Production BASF, China, Huntsman, SINOPEC, Shanghai, Shanghai Chlor-Alkali, Shanghai Hua Yi, mdi
BASF, Huntsman, Shanghai Hua Yi, Shanghai Chlor-Alkali and SINOPEC are teaming up to construct a new MDI plant in China. …
Astellas names Americas head
July 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Tatjana Dragovic, americas
Astellas has appointed Tatjana Dragovic as its VP and regional compliance officer for the firm’s Americas region. In this role …
Government gets £74m rebate from pharma
June 30, 2014Sales and Marketing ABPI, Hunt, NHS, PPRS, VBP, emms, pricing
The UK government has received a £74 million refund from the pharma industry after it was deemed to have spent …
FDA ‘yes’ to inhaled insulin
June 30, 2014Manufacturing and Production, Sales and Marketing Afrezza, FDA, Mannkind, diabetes, insulin human
The FDA has approved the first ‘ultra-rapid-acting’ mealtime insulin therapy available in the US, to improve glycemic control in both …
GSK China sex tape ‘sent to Witty’
June 30, 2014Medical Communications, Research and Development, Sales and Marketing China, GSK, Mark Reilly, Witty, corruption, sex tape
GlaxoSmithKline was scrambling to defend itself over the weekend as new details emerged concerning the extent of its suspected corruption …
CHMP approves six drugs including daclatasvir
June 30, 2014Sales and Marketing BMS, CHMP, HCV, Plavix, daclatasvir, daklinza, ge
A key advisory committee for the European Medicines Agency has given its approval to six new drugs at its latest …
Quantum Pharmaceutical adds head of commercial
June 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brown, quantum pharma
UK medicines supplier and manufacturing firm Quantum Pharmaceutical has expanded its team with the appointment of a new head of …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
